comparemela.com

Vivos Therapeutics, Inc. (VVOS)shares surged more than 263 percent on Wednesday morning trade after announcing FDA's 510(k) clearance for its removable CARE oral appliances to treat severe obstructive sleep apnea or OSA in adults.

Related Keywords

United Kingdom , ,Federal Reserve ,Rishi Sunak ,View More ,Fda ,Stock Alert ,Motivos ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.